We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
(+17%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$410M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$308M |
| 3 |
Eli Lilly
LLY
|
+$292M |
| 4 |
Costco
COST
|
+$291M |
| 5 |
Ford
F
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$368M |
| 3 |
Fair Isaac
FICO
|
+$197M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$194M |
| 5 |
Carrier Global
CARR
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.55% |
| 2 | Consumer Discretionary | 7.1% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
iQIYI
IQ
$1.18B
| $58.1K | ﹤0.01% |
32,797
-164,194
| -83% | -$295K |
|
4277
Patriot National Bancorp
PNBK
$132M
| $57.9K | ﹤0.01% |
+38,116
| New | +$103K |
|
4278
Ironwood Pharmaceuticals
IRWD
$611M
| $57.3K | ﹤0.01% |
+79,867
| New | +$62.7K |
|
|
NB
4279
NioCorp Developments
NB
$603M
| $56.7K | ﹤0.01% |
+24,353
| New | +$60.7K |
|
4280
Metagenomi Therapeutics
MGX
$45.4M
| $56.4K | ﹤0.01% |
+38,126
| New | +$59.7K |
|
|
MREO
4281
Mereo BioPharma
MREO
$45.9M
| $56K | ﹤0.01% |
20,668
+2,737
| +15% | +$6.61K |
|
|
YMAB
4282
DELISTED
Y-mAbs Therapeutics
YMAB
| $55.2K | ﹤0.01% |
12,233
-116,294
| -90% | -$523K |
|
4283
Compass Therapeutics
CMPX
$373M
| $54K | ﹤0.01% |
+20,773
| New | +$42.8K |
|
4284
Wrap Technologies
WRAP
$94.8M
| $53.9K | ﹤0.01% |
+34,559
| New | +$52K |
|
4285
Zentalis Pharmaceuticals
ZNTL
$308M
| $53.9K | ﹤0.01% |
46,461
-2,641
| -5% | -$3.48K |
|
4286
Conduent
CNDT
$230M
| $53.5K | ﹤0.01% |
+20,254
| New | +$47.6K |
|
|
SOND
4287
DELISTED
Sonder
SOND
| $53K | ﹤0.01% |
19,633
-209
| -1% | -$423 |
|
|
IAUX
4288
i-80 Gold Corp
IAUX
$1.17B
| $52.7K | ﹤0.01% |
+88,062
| New | +$51.9K |
|
4289
Standard BioTools
LAB
$326M
| $51.9K | ﹤0.01% |
+43,253
| New | +$47.9K |
|
4290
PUT
Denison Mines
DNN
$2.63B
| $51.3K | ﹤0.01% |
28,200
-200
| -0.7% | -$303 |
|
|
BRSP
4291
BrightSpire Capital
BRSP
$681M
| $51.1K | ﹤0.01% |
+10,112
| New | +$51.1K |
|
4292
American Battery Technology Co
ABAT
$301M
| $50.7K | ﹤0.01% |
+31,277
| New | +$40.6K |
|
4293
Microvision
MVIS
$88.2M
| $50.6K | ﹤0.01% |
44,421
-222,678
| -83% | -$257K |
|
|
CGC
4294
Canopy Growth
CGC
$375M
| $50.4K | ﹤0.01% |
+41,339
| New | +$55K |
|
4295
Wheels Up
UP
$220M
| $50.4K | ﹤0.01% |
+2,356
| New | +$57.9K |
|
4296
Cato Corp
CATO
$65.9M
| $50.2K | ﹤0.01% |
+17,855
| New | +$47.5K |
|
4297
MaxCyte
MXCT
$116M
| $50.1K | ﹤0.01% |
22,999
-39,605
| -63% | -$95.9K |
|
4298
Genasys
GNSS
$75.6M
| $50K | ﹤0.01% |
+28,909
| New | +$53.3K |
|
4299
CALL
PDS Biotechnology
PDSB
$38.1M
| $49.5K | ﹤0.01% |
37,200
| – | – |
|
4300
AbCellera Biologics
ABCL
$1.62B
| $49.1K | ﹤0.01% |
14,319
-4,431
| -24% | -$11K |
|
Similar funds
Squarepoint's Q2 2025 Portfolio in Review
As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
- Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
- Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
- Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
- Squarepoint opened 767 new positions and closed 817 in Q2 2025.
- Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.